Skip to main content

Novavax, Emergent BioSolutions Expand Partnership to Include Flu Vaccine

Maryland biotech companies Emergent BioSolutions Inc. and Novavax have expanded their partnership to include production of an influenza vaccine. Emergent will guide the NanoFlu vaccine to the commercial manufacturing stage at its Bayview location in Baltimore City, according to the Baltimore Business Journal. This comes just weeks after the two companies announced a partnership to develop a COVID-19 vaccine.


Read More